Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Mol Cancer Ther. 2018 Jul 3;17(9):1893–1901. doi: 10.1158/1535-7163.MCT-17-0600

Fig. 3.

Fig. 3

BBB permeability and distribution of SAR405838 in GBM108-Vector and GBM108-VEGFA

A) Comparison of BBB permeability to Texas Red Dextran in GBM108-Vector and GBM108-VEGFA (scale bar = 1000 um) B) Contrast enhancement on MRI for GBM108-Vector and GBM108-VEGFA C) Comparison of H&E staining in GBM108-Vector and GBM108-VEGFA with MALDI mass spectrometry imaging for Gadavist and SAR405838. Dotted lines on the H&E stained section images delineate GBM108-Vector and GBM108-VEGFA tumors.